Description
Contents: 25 Individually packaged test cassettes, buffer tubes and swabs, tube holders, quick reference guide, instructions for use
Regulatory Status: CLIA Waived, FDA De Novo
Determinations: Detection of the COVID-19 (SARS-CoV-2), Influenza A, and Influenza B
Processing Time: 15 Minutes
One test. Three targets. Clinical clarity. The INDICAID COVID-19 Influenza A&B point-of-care test offers fast, accurate, and actionable results for three respiratory viruses using a single nasal swab. Designed for point-of-care (POC) settings, it empowers clinical decision-making when timing matters most.
- CLIA-waived for POC: Use in urgent care, clinics, schools, and employer health programs
- Differentiates overlapping symptoms: Helps guide proper antiviral or isolation protocols
- Highly accurate: COVID-19 sensitivity: 92%, Influenza A sensitivity: 92.5%, and Influenza B sensitivity: 90.5%
- Easy sampling: Utilizes a shallow nasal swab and suitable for individuals aged 14 years or older testing themselves, or adults testing individuals aged 2 years or older
Product Resources:
